Tau promoter confers neuronal specificity and binds Sp1 and AP-2
about
Circulating microRNAs in Alzheimer's disease: the search for novel biomarkersShort-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease miceIntegrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.Concerted perturbation observed in a hub network in Alzheimer's diseaseEnhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.Regulation of human MAPT gene expression.Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and miceTau exon 10 alternative splicing and tauopathiesLinks between copper and cholesterol in Alzheimer's disease.Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsyGC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35.Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1.Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 Diabetes.Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease.Copper and Alzheimer's Disease.Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval.DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain.Neuronal precursor-specific activity of a human doublecortin regulatory sequence.The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
P2860
Q27021084-6B02C39F-8E59-429E-AFE8-946BB0C09B78Q30541295-42359B85-577D-41CB-9F85-C79E13E5E41CQ34202948-F3B680A7-3DAA-423E-AFC8-EF6073517C12Q34344867-9C5E88D9-7480-4ADA-99A5-A574C177D435Q34655631-90F417C6-BFA7-4482-8980-81AEB5086C61Q35264520-A42400CA-0F7E-4914-B527-01E1180DCDFBQ35844758-21A48E16-6ABB-4552-9F57-7FA5A5894597Q36603312-01E7E6C5-0888-4643-AC93-D65DEF0FBEC8Q36789895-5963BC86-ABE9-46B8-B03D-9CEAF73258B5Q36847737-3A43D74D-B0CF-4199-88CD-B00EEB35CBBDQ37186173-C4383341-345D-493B-B2CD-357D56115101Q37417119-8351FB9E-DD82-4F1E-9624-272D3A6BF149Q37535111-22F06A5D-E691-4167-A99E-03A685E124D1Q38294385-2E61376A-711E-4387-8AED-6389C7CD1A70Q39274764-A2698B89-61C6-4EC7-AF5B-FB61780635E5Q39920234-5AD3110F-E5C9-41BA-A264-54AD72933015Q41328860-7710AEAE-BE9A-4B3E-80C6-EA9973969C17Q41583234-92F19ABE-0A17-4CA3-BE51-75583AC4BA75Q43106647-4F60CF9D-9421-457B-A716-F52FA70AACE5Q46309586-BEA753B7-641C-473A-80B8-A36D04B0D5F1Q48428753-EE93ABA2-19F2-4BE9-B660-0F45467280BBQ48521070-0AEB2F20-5515-4550-9A3A-94CCDD57AC32Q49126350-D9876DCB-118C-42FA-8D86-2403D425CEC6Q50306250-32A68F6A-2DFD-4C62-B2B0-756DD61198DCQ50520724-1DD93401-4476-4C44-8AEC-1F242AB62F79
P2860
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@ast
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en-gb
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@nl
type
label
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@ast
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en-gb
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@nl
prefLabel
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@ast
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en-gb
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@nl
P2860
P1476
Tau promoter confers neuronal specificity and binds Sp1 and AP-2
@en
P2093
A Heicklen-Klein
I Ginzburg
P2860
P304
P356
10.1046/J.1471-4159.2000.0751408.X
P407
P577
2000-10-01T00:00:00Z